Industry Reports
Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2016
Johnson & Johnson today announced that its Board of Directors has declared a cash dividend for the third quarter of 2016 of $0.80 per...
Industry Reports
Johnson & Johnson Announces Completion of Acquisition of Vogue International LLC
Johnson & Johnson announced that Johnson & Johnson Consumer Inc. has successfully completed the acquisition of Vogue International LLC, a privately-held company focused on...
News
Open House Marchesini Group: the countdown to the opening of the biggest thermoforming hub in Italy has begun
The Thermoforming Hub Open House of Marchesini Group is one of the most long-awaited events of next Autumn for the Italian pharmaceutical industry. The...
News
Glaxosmithkline plc- ARIA Study Shows Superior Efficacy of Triumeq® for Treatment-naïve women living with HIV
ViiV Healthcare presented 48-week data from the phase IIIb, open-label, international, multi-centre ARIA study which showed superior efficacy for Triumeq® (dolutegravir/abacavir/lamivudine) compared with atazanavir...
Press Releases
EMA accepts Merck’s MAA for cladribine tablets in multiple sclerosis
Merck, a leading science and technology company announced that the EMA to request the company for marketing approval for its investigational Cladribine Tablets for...
News
Allergan Plc Files Application to FDA for Approval of Oculeve Intranasal Tear Neurostimulator
Allergan plc announced that it has filed with the U.S. FDA the de novo application for the Oculeve Intranasal Tear Neurostimulator device. According to...
Press Releases
Biogen SB5 accepted for review by European Medicines Agency
The Marketing Authorization Application (MAA) for SB5, an adalimumab biosimilar candidate referencing Humira®1, has been accepted for review by the EMA. The MAA for...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read